UBS Group
RGNT

UBS Group’s Regentis Biomaterials RGNT Stock Holding History

UBS Group’s Portfolio RGNT Stock Details RGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02K Buy
+334
New +$1.6K ﹤0.01% 9642

Other funds holding RGNT

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

UBS Group's RGNT Position: Q1 2026 in Review

UBS Group opened a new position in Regentis Biomaterials (RGNT) in Q1 2026: 334 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #9642 among its holdings.

3 funds tracked by Wall St. Rank hold RGNT as of Q1 2026.

  • UBS Group held 334 shares of Regentis Biomaterials worth $1.02K as of Q1 2026.
  • Regentis Biomaterials was a new UBS Group position in Q1 2026.
  • Regentis Biomaterials made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9642 holding.
  • 3 funds tracked by Wall St. Rank held Regentis Biomaterials as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.